CASEY COLANGELO: Open Payments
NPI 1821613191 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,401 in 121 payments from 18 companies in 2025. Trend: 2023 $2,811 · 2024 $1,634 · 2025 $2,401
Food & beverage: $2,372Education: $29
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $756 |
| UCB, Inc. | 13 | $363 |
| LEO Pharma Inc. | 5 | $238 |
| Organon LLC | 7 | $235 |
| Galderma Laboratories, L.P. | 16 | $160 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $132 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Janssen Biotech, Inc. | 5 | $84 |
| Incyte Corporation | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
Products named: Bimzelx, SKYRIZI, ANZUPGO, BOTOX, VTAMA, ILUMYA, NEMLUVIO, TREMFYA.
Industry payments across NJ — which companies pay providers there.
